Pembrolizumab shows promise in pretreated metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
List view / Grid view
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
20 July 2015 | By Victoria White
UCLA Health was a victim of a criminal cyber attack and data on as many as 4.5 million individuals potentially may have been involved in the attack...